EGF and neoplasm: As the tumour progresses, the number of immunosuppressive M2-like TAMs increases, which in turn promotes tumour progression by secreting EGF, VEGF, and MMPs; these factors promote cancer cell proliferation, angiogenesis, and invasion and a pre-metastatic niche, respectively.